BackMAIA Biotechnology Overview
MAIA Biotechnology Inc

MAIA Biotechnology Return on Equity

MAIA Biotechnology (MAIA) has a ROE of -171.24%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-171.24%

Return on Equity

-171.24%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

MAIA Biotechnology (MAIA) FAQ

MAIA Biotechnology posts a ROE of -171.24%. That is below the sector sector average of 11.3%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.3% is typical. MAIA Biotechnology's -171.24% is lower that level. That is roughly 1615.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

MAIA Biotechnology's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -171.24%; use YoY and peer views to separate noise from signal.

Context for MAIA's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.3%), and (3) consistency with growth and profitability. This page covers the first two; MAIA Biotechnology's other metric pages and overview cover the third.